Yang Ying, Shi Ning
Xi'an Weiyang FRESKIN Medical Cosmetology Clinic Co., LTD. Xi'an 710000, Shaanxi, China.
Chengdu Ningyue FRESKIN Medical Cosmetology Clinic Co., LTD. Chengdu 610000, Sichuan, China.
Am J Transl Res. 2024 Jun 15;16(6):2607-2611. doi: 10.62347/NFNB7436. eCollection 2024.
To assess the effectiveness and safety of poly-L-lactic acid (PLLA) fillers in treating nasal alar retraction. We conducted a series of case reports on 13 patients treated for nasal alar retraction at the Chengdu Ningyue FRESKIN Medicine Cosmology Clinic from September 2022 to July 2023. Patients ranged from 23 to 49 years, comprising 12 females and 1 male. Of these, 5 had no prior medical history, 7 had previously undergone rhinoplasty, and 1 had a history of nasal trauma. Treatment outcomes and adverse reactions were monitored following PLLA filler injections. The mean pre-treatment severity score was 1.62±0.65, improving to 0.54±0.66 post-treatment (t=4.19, df=23, P<0.001). All participants reported satisfaction with their results without adverse effects. PLLA facial fillers are a safe and effective treatment for nasal alar retraction, presenting no embolism risk. This treatment merits consideration for broader clinical application.
评估聚左旋乳酸（PLLA）填充剂治疗鼻翼退缩的有效性和安全性。我们对2022年9月至2023年7月在成都宁悦芙思肌肤医学美容诊所接受鼻翼退缩治疗的13例患者进行了一系列病例报告。患者年龄在23至49岁之间，其中女性12例，男性1例。其中，5例无既往病史，7例曾接受过隆鼻手术，1例有鼻外伤史。在注射PLLA填充剂后监测治疗效果和不良反应。治疗前平均严重程度评分为1.62±0.65，治疗后改善至0.54±0.66（t=4.19，自由度=23，P<0.001）。所有参与者均对治疗结果表示满意，且未出现不良反应。PLLA面部填充剂是治疗鼻翼退缩的一种安全有效的方法，不存在栓塞风险。这种治疗方法值得考虑更广泛地应用于临床。
